Gross Profit On Sales Changement Date
AbbVie USD 9.34B 1.36B 2025-03
Abbott USD 5.87B 50M 2025-06
ALKERMES USD 257.77M 462K 2025-06
Amgen USD 5.54B 430M 2025-03
AstraZeneca USD 11.98B 637M 2025-06
Bayer EUR 8.11B 2.11B 2025-03
Biogen USD 2.04B 238.8M 2025-06
Bristol-Myers Squibb USD 8.9B 714M 2025-06
Drreddys Laboratories INR 49.05B 1.28B 2024-12
Eli Lilly USD 10.5B 624.7M 2025-03
Gilead Sciences USD 5.58B 453M 2025-06
GlaxoSmithKline GBP 5.82B 229M 2025-06
Glaxosmithkline GBP 5.6B 94M 2024-12
J&J USD 14.6B 816M 2025-03
Medtronic USD 5.81B 296M 2025-04
Merck USD 12.99B 224M 2025-06
Neurocrine Biosciences USD 676.2M 112.8M 2025-06
Novartis USD 11.51B 1.12B 2025-06
Novartis USD 10.24B 313M 2024-12
Pacira USD 125.91M 8.71M 2025-06
Perrigo USD 362.9M 29.4M 2025-06
Pfizer USD 11.12B 987M 2025-03
Prestige Brands USD 140.33M 29.68M 2025-06
Regeneron Pharmaceuticals USD 3.15B 581M 2025-06
Roche Holding CHF 11.69B 48M 2024-12
Sanofi EUR 7.74B 26M 2025-06
Sanofi EUR 5.36B 4.71B 2024-12
Vertex Pharmaceuticals USD 2.56B 150M 2025-06
Zoetis USD 1.78B 180M 2025-06


Pfizer La Marge Brute Sur Les Ventes - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Aug 2025.